Literature DB >> 12666228

Fetal thoracoamniotic shunting as the only treatment for pulmonary sequestration with hydrops: favorable long-term outcome without postnatal surgery.

L J Salomon1, F Audibert, M Dommergues, M Vial, R Frydman.   

Abstract

Although it is established that bronchopulmonary sequestration complicated by fetal hydrops carries a high risk of perinatal mortality, prenatal management remains controversial. Therapeutic options include immediate delivery, medical therapy based on an inotropic regimen, alcohol ablation of the vascular pedicle, open fetal surgery, or thoracoamniotic shunting of fetal pleural effusions. We report a case of pulmonary sequestration with hydrothorax and fetal hydrops which was successfully treated by a single fetal thoracoamniotic catheter drainage. Following emergency catheter placement, hydrothorax and hydrops decreased dramatically. The sequestration gradually disappeared postnatally, and long-term outcome remained normal without any postnatal therapy. Based on this observation, the natural history of pulmonary sequestration and prenatal management options are reviewed. Copyright 2003 ISUOG. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2003        PMID: 12666228     DOI: 10.1002/uog.76

Source DB:  PubMed          Journal:  Ultrasound Obstet Gynecol        ISSN: 0960-7692            Impact factor:   7.299


  2 in total

1.  Fetal hydrops in experimental obstructive uropathy resolves after vesicostomy formation: is this cause and effect?

Authors:  Hiroaki Kitagawa; Kevin C Pringle; Junki Koike; Jane Zuccollo; Yuriko Sato; Hideaki Sato; Takeshi Aoba; Yasuji Seki; Munechika Wakisaka; Koonosuke Nakada
Journal:  Pediatr Surg Int       Date:  2005-01       Impact factor: 1.827

2.  Management Options for Fetal Bronchopulmonary Sequestration.

Authors:  Magdalena Litwinska; Ewelina Litwinska; Krzysztof Szaflik; Marzena Debska; Tomasz Szajner; Katarzyna Janiak; Piotr Kaczmarek; Miroslaw Wielgos
Journal:  J Clin Med       Date:  2022-03-20       Impact factor: 4.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.